Venus Medtech Europe

Venus Medtech Europe is the European branch of Venus Medtech (Hangzhou) Inc., a prominent medical device company based in Hangzhou, China. Founded in 2009, the company specializes in the design, development, and commercialization of transcatheter heart valve products aimed at treating structural heart diseases. Venus Medtech has established itself as a leader in the transcatheter heart valve market, particularly in China. The company focuses on minimally invasive cardiac valve treatments, offering a range of advanced artificial valve systems for aortic, pulmonary, mitral, and tricuspid valve diseases. Its product lineup includes solutions like the Venus-PowerX and VenusA-Valve series for aortic valve stenosis, the VenusP-Valve for pulmonary regurgitation, and devices for mitral and tricuspid valve conditions. Venus Medtech Europe is also involved in clinical trials and has seen significant growth in European sales, contributing to its global expansion across nearly 70 countries. The company is committed to innovation and holds a strong intellectual property portfolio, supporting its mission to advance transcatheter heart valve technologies.

• Employees 8
• Total Funding $190000000